Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2003
06/05/2003US20030104548 For stimulationg release of tumor necrosis factor and/or cellular proliferation/differeniation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104547 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104545 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104544 For stimulating release of tumor necrosis factor and or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104532 Neuroprotectants; angoigenesis inhibitors; transcription factors
06/05/2003US20030104531 DNA molecules encoding human nuclear receptor protein nNR7-1
06/05/2003US20030104528 Lymphocytes; transcription factors; interferons
06/05/2003US20030104523 Process for high throughput screening of CpG-based immuno-agonist/antagonist
06/05/2003US20030104517 Kinesin light chain homolog
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104499 Kits for use in diagnosis of cell proliferative disorders
06/05/2003US20030104485 Antibodies specific for osteoprotegerin binding proteins and method of use
06/05/2003US20030104482 Death associated kinase containing ankyrin repeats (DAKAR)
06/05/2003US20030104479 Novel fusion proteins and assays for molecular binding
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104469 Nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of gastrointestinal, cancer and kidney disorders
06/05/2003US20030104450 Novel regulator of g protein signalling
06/05/2003US20030104444 Plasmids for use as tools in treatment and prevention of nervous system, cancer and viral disorders
06/05/2003US20030104423 Transcriptional modulator for use as tool in controlling gene expression
06/05/2003US20030104422 Nucleotide sequences coding enztmatic polypeptide for use as diagnostic tool in genetic engineering
06/05/2003US20030104419 Method of classifying a thyroid carcinoma using differential gene expression
06/05/2003US20030104406 Modified and stabilized GDF propeptides and uses thereof
06/05/2003US20030104401 Gene silencing using sense DNA and antisense RNA hybrid constructs
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030104399 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of body weight and aging disorders
06/05/2003US20030104384 Trangenic cell library for monitoring phenotypic adjustments associated with gene transfer
06/05/2003US20030104381 Nucleotide sequences coding polypeptide for use in treatment of heart, cancer and skin disorders
06/05/2003US20030104379 HY2 family of bilin reductases
06/05/2003US20030104374 Gene encoding MNR2 and uses thereof
06/05/2003US20030104365 Polypeptide for use in the diagnosis and treatment of alzheimer's disease
06/05/2003US20030104359 Apparatus for use in the recovery of preferential particles in a sample
06/05/2003US20030104358 Polynucleotides for use in the detection of obesity, cancer, stroke, atherosclerosis, osteoarthritis, diabetes, asthma and autoimmune diseases
06/05/2003US20030104357 Jaagsiekte sheep retroviral packaging cell lines and methods relating thereto
06/05/2003US20030104355 Adapter-directed display systems
06/05/2003US20030104011 Inactivated reverse transcriptase.
06/05/2003US20030104009 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
06/05/2003US20030103997 Can be used to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection
06/05/2003US20030103994 Comprising lung tumor polypeptides or immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cells that expresses such polypeptides, T cells specific for cells expressing such polypeptides
06/05/2003US20030103988 Regulation of activated t cells by recognition of t cell receptor beta chains and major histocompatibility complex class ib molecules
06/05/2003US20030103978 Antibodies and antigen binding domains used to prevent or treat conditions relating to loss of bone mass and bone disorders; nucleic acid encoding antibodies and antigen binding domains
06/05/2003US20030103958 Gene expression; for catalysis of phytate to inositol and inorganic phosphate; heat resistance; for production of animal feeds
06/05/2003US20030103957 Comprises adenosine-diphosphate transferase activity; drug delivery; for suppressing inhibition of neuronal axon growth
06/05/2003US20030103951 Cardiac muscle regeneration using mesenchymal stem cells
06/05/2003US20030103950 For production of a tooth progenitor cell; genetic engineering
06/05/2003US20030103949 Cell proliferation
06/05/2003US20030103947 Stem cells obtained from bone which differentiate into cells of more than one connective tissue type
06/05/2003US20030103946 Immunotherapeutic methods and molecules
06/05/2003US20030103945 Methods and compositions for stimulating axon regeneration and preventing neuronal cell degeneration
06/05/2003US20030103943 Multiple site delivery of adenoviral vector for the induction of angiogenesis
06/05/2003US20030103942 Comprises recombinant adeno-associated virus vectors encoding TNF antagonist; antiinflammatory agents for connective tissues and joints
06/05/2003US20030103939 For enhanced transduction of eukaryotic cells; gene expression
06/05/2003US20030103938 Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003US20030103936 Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptides
06/05/2003CA2852277A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2468970A1 Process for producing substance
06/05/2003CA2468950A1 Anti-il13 receptor .alpha.1 neutralizing antibody
06/05/2003CA2468832A1 Method for producing a recombinant polypeptide
06/05/2003CA2468353A1 A novel homeobox gene
06/05/2003CA2468323A1 Method for improving functionality of tissue constructs
06/05/2003CA2468320A1 Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist and a toll-like receptor agonist
06/05/2003CA2468316A1 Novel compositions and methods for cancer
06/05/2003CA2468310A1 Eb matrix production from animal tissue and its use for tissue repair
06/05/2003CA2468292A1 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
06/05/2003CA2468246A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
06/05/2003CA2468245A1 Magneto-optical bio-discs and systems including related methods
06/05/2003CA2468131A1 Disruption of the prostaglandin e synthase 2 gene
06/05/2003CA2467858A1 Dna construct for assessing thymic function activity and therapeutical uses thereof
06/05/2003CA2467581A1 Milk protein biofilm and uses thereof
06/05/2003CA2467397A1 Flavivirus vaccine delivery system
06/05/2003CA2467202A1 Expression of polypeptides in rod outer segment membranes
06/05/2003CA2466881A1 Cell culture process
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466431A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2454397A1 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns
06/04/2003EP1316609A1 Acetoacetyl-CoA thiolase and its use for identifying new fungicidal substances
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1316321A1 Base materials for tissue regeneration, transplant materials and process for producing the same
06/04/2003EP1316252A1 Disease-resistant plants and method of constructing the same
06/04/2003EP1315971A2 Model for alzheimer's disease and other neurodegenerative diseases
06/04/2003EP1315835A2 Directed differentiation of embryonic cells
06/04/2003EP1315831A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
06/04/2003EP1315829A1 Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
06/04/2003EP1315823A2 Methods for stable transduction of cells with viral vectors
06/04/2003EP1315821A2 Reporter system for cell surface receptor-ligand binding
06/04/2003EP1315813A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315810A2 Family member of inhibitor of apoptosis proteins
06/04/2003EP1315809A2 Control of crop pests and animal parasites through direct neuronal uptake
06/04/2003EP1315808A2 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target
06/04/2003EP1315805A2 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315798A2 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
06/04/2003EP1315797A2 In vitro human angiogenesis model
06/04/2003EP1315796A2 Decellularized tissue engineered constructs and tissues
06/04/2003EP1315794A1 Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation
06/04/2003EP1315793A1 Methods for culturing human lung mast cells and uses thereof
06/04/2003EP1315760A2 Endoglin-specific polypeptide, production and use thereof
06/04/2003EP1315756A2 Electroprocessed fibrin-based matrices and tissues
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315754A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
1 ... 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 ... 1827